Integrated BioTherapeutics Inc. and Integral Molecular Collaborate to Engineer Broadly Protective Ebolavirus Vaccines
Next-generation vaccine design strategies to protect against Ebola and related
Next-generation vaccine design strategies to protect against Ebola and related
Contract to support manufacturing and a Phase 1 clinical trial
IBT is pioneering the development of the first multivalent toxoid-based
Copenhagen, Denmark, 06 January 2020 - Today, the Novo Holdings REPAIR Impact Fund
Freeze-dried version of vaccine would boost availability to the world,
IBT in collaboration with Dr. Daniel Nelson’s lab at University
IBT in collaboration with the laboratory of Dr. Brandon Dekosky,
IBT in collaboration with the laboratory of Dr. Brandon Dekosky,
IBT in collaboration with Abviro, LLC (Bethesda, MD) received a
IBT in collaboration with Dr. Jean Lee lab at Brigham